Glutathione and Fuel Oxidation in Aging

• ClinicalTrials.gov Identifier: NCT01870193
• Recruitment Status: Recruiting
• First Posted: June 5, 2013
• Last Update Posted: February 26, 2019
• Sponsor: Rajagopal V Sekhar
• Collaborator: National Institute on Aging (NIA)
• Information provided by (Responsible Party): Rajagopal V Sekhar, Baylor College of Medicine

Study Description

Brief Summary:

Glutathione is an important antioxidant protein which protects cells from harmful oxidative stress. Elderly humans are known to have elevated oxidative stress and deficiency of glutathione, but it is not known whether there is deficient synthesis of glutathione in muscle tissue of elderly humans.

Mitochondria are engines of cells where food consumed is burned to make energy. Under normal conditions the fuel of choice in the fasted state is fat, but fasted elderly humans are not able to oxidize fat as well as healthy young humans. Elderly humans also have the highest incidence and prevalence of being overweight and obese, and have increased storage of fat in liver and muscle.

This study will help determine whether

1. elderly humans have diminished synthesis of glutathione in the skeletal muscle, and whether this can be improved by supplementing cysteine and glycine (and not an isonitrogenous placebo) in the diet;
2. improving muscle glutathione concentrations can also improve fuel oxidation in aging;
3. improvement of intracellular glutathione concentrations will be associated with a change in total body fat content

Condition or disease	Intervention/treatment
Aging	Dietary Supplement: Glycine, cysteine (as n-acetylcysteine), alanine

Detailed Description:

Subjects will be recruited by written informed consent on forms approved by the Institutional Review Board of Baylor College of Medicine at the time of approval of the full protocol. Subjects taking an nonvitamin supplements or lipid lowering medications will stop this 4 weeks before the screening labs and for the entire duration of the study. Fasted subjects will have screening labs (blood count, HbA1c, lipid profile, liver profile, blood urea nitrogen, Creatinine, thyroid stimulating hormone, free t4, cortisol) followed by an oral glucose tolerance test, measures of muscle strength by dynamometry, tests of function (including a 6-min walk test) and body composition scans to measure total body fat. On another occasion, fasted subjects will be undergo stable isotope infusions and other studies in the metabolic research unit to measure concentrations of amino-acids and glutathione in red blood cells and muscle tissue, glutathione synthesis rates in muscle and red cells, plasma and whole-body mitochondrial fatty-acid oxidation, Kreb's cycle function, urine urea nitrogen, plasma reactive oxygen species and F2-isoprostanes, genes of glutathione synthesis and fuel oxidation. Elderly subjects will also have magnetic resonance spectroscopy scan for liver and muscle fat content.

Young subjects will be given dietary cysteine and glycine for 2-weeks and be restudied 2-weeks later. They are then released from the study.

Elderly subjects will be studied for 16 weeks. They will be assigned to receive either cysteine plus glycine, or alanine in a randomized, double-blinded study design. The studies described above will be repeated after 2 weeks and 16 weeks. Subjects will have monthly measures of liver profile, lipid profiles, BUN and creatinine and glutathione.

Study Design

• Study Type: Observational
• Estimated Enrollment: 36 participants
• Observational Model: Case-Control
• Time Perspective: Prospective
• Official Title: Glutathione and Fuel Oxidation in Aging
• Study Start Date: October 2012
• Estimated Primary Completion Date: December 2019
• Estimated Study Completion Date: December 2019

Groups and Cohorts

Group/Cohort	Intervention/treatment
Young controls; Young controls will be studied before and after receiving cysteine and glycine for 2 weeks	Dietary Supplement: Glycine, cysteine (as n-acetylcysteine), alanine; Young controls will receive cysteine plus glycine for 2 weeks The elderly subjects will be randomized in a double-blinded design to receive either cysteine plus glycine OR alanine for a period of 4 months
Elderly group; Elderly subjects will be randomized in a double-blinded design to receive either cysteine plus glycine or alanine for 4 months, and be studied at baseline, 2 weeks and 4 months	Dietary Supplement: Glycine, cysteine (as n-acetylcysteine), alanine; Young controls will receive cysteine plus glycine for 2 weeks The elderly subjects will be randomized in a double-blinded design to receive either cysteine plus glycine OR alanine for a period of 4 months

Outcome Measures

Primary Outcome Measures :

1. Muscle glutathione concentration [ Time Frame: Each subject will be studied over 4 months ]

Biospecimen Retention:   Samples With DNA

Breath, blood and muscle tissue

Eligibility Criteria

• Ages Eligible for Study: 21 Years to 80 Years (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes
• Sampling Method: Non-Probability Sample

Study Population

Community sample

Criteria

Inclusion Criteria:

1. Elderly subjects: age range 61-80y.
2. Young healthy subjects: age range 21-40y

Exclusion Criteria:

1. Renal impairment (serum creatinine >1.5 mg/dL)
2. Liver impairment (liver transaminases >2x upper limit of normal)
3. Untreated/uncontrolled hyperthyroidism or hypothyroidism
4. Known hypercortisolemia
5. Known diabetes mellitus
6. Hospitalization in the past 3 months
7. BMI <27 (elderly group)
8. Elderly women on estrogen replacement
9. Known pre-existing coronary artery disease
10. Fasted plasma triglyceride >300 mg/dl (on lipid lowering medications)
11. Fasted plasma triglyceride >500 mg/dl (off lipid lowering medications)

Contacts and Locations

Locations

United States, Texas

Baylor College of Medicine; Recruiting

Houston, Texas, United States, 77030

Contact: R V Sekhar, MD 713-798-4951

Principal Investigator: R V Sekhar, MD

Sponsors and Collaborators

Rajagopal V Sekhar

National Institute on Aging (NIA)

Investigators

• Principal Investigator: R V Sekhar, MD; Baylor College of Medicine

More Information

• Responsible Party: Rajagopal V Sekhar, Associate Professor, Baylor College of Medicine
• ClinicalTrials.gov Identifier: NCT01870193 History of Changes
• Other Study ID Numbers: H-30681 GSH-Aging; R01AG041782 ( U.S. NIH Grant/Contract )
• First Posted: June 5, 2013
• Last Update Posted: February 26, 2019
• Last Verified: February 2019

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No

Keywords provided by Rajagopal V Sekhar, Baylor College of Medicine:

Glutathione deficiency in aging; Impaired mitochondrial fatty-acid oxidation in aging

Additional relevant MeSH terms:

Acetylcysteine; Glycine; Antiviral Agents; Anti-Infective Agents; Expectorants; Respiratory System Agents; Free Radical Scavengers; Antioxidants; Molecular Mechanisms of Pharmacological Action; Protective Agents; Physiological Effects of Drugs; Glycine Agents; Neurotransmitter Agents